NSCLC

Latest News

Medicaid Enrollees Appear To Be Missing Out on Targeted Treatment for NSCLC, Harvard Researchers Find
Medicaid Enrollees Appear To Be Missing Out on Targeted Treatment for NSCLC, Harvard Researchers Find

January 25th 2023

1 out 3 Medicaid patients who might have benefited from targeted therapy —mainly Tagrisso and Alecensa — for metastatic lung cancer did not receive it, according to estimates by a trio Harvard-affiliated researchers.

Keytruda Plus Platinum-based Chemotherapy Comes Out on Top in Network Meta-analysis
Keytruda Plus Platinum-based Chemotherapy Comes Out on Top in Network Meta-analysis

September 27th 2021

The Mainstreaming  of Targeted Lung Cancer Treatment
The Mainstreaming of Targeted Lung Cancer Treatment

September 14th 2021

Research Identifies Mutational Signatures of Nonsmall Cell Lung Cancer Tumors in Never Smokers
Research Identifies Mutational Signatures of Nonsmall Cell Lung Cancer Tumors in Never Smokers

September 9th 2021

Hypofractionated Radiotherapy Fails to Extend Survival in NSCLC Patients Ineligible for Concurrent Chemoradiotherapy
Hypofractionated Radiotherapy Fails to Extend Survival in NSCLC Patients Ineligible for Concurrent Chemoradiotherapy

September 1st 2021

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.